EV cargo analysis: proteomics, transcriptomics, lipidomics

Every extracellular vesicles (EV) is a parcel of molecular cargo, proteins, RNA, lipids and metabolites, drawn from the cell that released it and capable of changing the behaviour of the cell that takes it up. Reading that cargo is how researchers turn a population of nanoparticles into biological information: a signature of the parent cell's state, a candidate biomarker, or a clue to how a vesicle exerts its effect. Three analytical layers dominate this work. Proteomics catalogues the proteins, transcriptomics profiles the RNA, and lipidomics maps the membrane lipids. Together they form the core of EV cargo analysis.

This article walks through each of the three layers in turn: what is measured, the methods used to measure it, and the practical pitfalls that determine whether the data hold up. It then looks at how the layers are integrated through multi-omics and community databases, and why the single most important factor across all three is not the analytical instrument but the quality of the EV preparation that feeds it.

What is in an Extracellular Vesicle?

EVs are membrane-bound particles released by virtually all cell types, spanning small exosomes (roughly 30 to 150 nm, formed within multivesicular bodies) and larger microvesicles that bud from the plasma membrane. Whatever their size, they enclose a selected sample of the parent cell: cytosolic and membrane proteins, messenger and non-coding RNA, a distinctive complement of lipids, and a range of metabolites. Critically, this cargo is not a random scoop of cellular contents. Sorting machinery enriches some molecules and excludes others, so the vesicle population carries a biased, informative signature rather than a faithful copy of the cell.

That selectivity is what makes cargo analysis worthwhile, and also what makes it hard. The molecules of interest are present in tiny amounts, packaged inside a fragile membrane, and surrounded in any biofluid by a vast excess of non-vesicular material. Each omics layer has developed its own strategies for extracting signal from that background, and each has its own characteristic failure mode.

Proteomics: Reading the EV Protein Cargo

Proteins are the most studied component of the EV cargo, and mass spectrometry is the workhorse of the field. In a typical bottom-up workflow, vesicle proteins are extracted, digested into peptides (usually with trypsin) and separated by liquid chromatography before tandem mass spectrometry (LC-MS/MS) identifies and quantifies them. The output is a list of proteins and their relative or absolute abundances, often running to hundreds or thousands of identifications from a single preparation.

EV proteomes are characterised by a recurring core of vesicle-associated proteins: tetraspanins such as CD9, CD63 and CD81; endosomal sorting proteins including TSG101 and ALIX; heat-shock proteins; and a variable cast of cell-type-specific surface markers that report on the vesicle's origin. Beyond simple inventory, quantitative approaches (label-free quantification, or isobaric tagging such as TMT) allow protein abundances to be compared between conditions, and targeted methods can track specific candidate biomarkers across patient cohorts. Post-translational modifications, protein interactions and surface topology are increasingly accessible as instrument sensitivity improves.

The dominant challenge is contamination and dynamic range. In plasma or serum, abundant soluble proteins such as albumin and immunoglobulins, together with lipoproteins, can swamp the genuine vesicular signal unless removed during isolation. Low sample input compounds the problem, since EV preparations often yield only microgram or sub-microgram quantities of protein. These constraints are precisely why isolation method and purity assessment are treated as part of the proteomic workflow rather than a preliminary step, and why immunocapture and single-vesicle approaches are being developed to interrogate defined EV subpopulations.

Transcriptomics: The RNA Inside EVs

The recognition that EVs carry functional RNA, and can deliver it to recipient cells, reshaped the field. Early work showing that vesicles transfer messenger RNA and microRNA between cells established RNA as a bona fide signalling cargo, and microRNAs in particular have driven enormous interest as minimally invasive biomarkers. Today, small RNA sequencing (small RNA-seq) is the principal tool for profiling the EV transcriptome, complemented by quantitative PCR for targeted measurement and by long-RNA sequencing for messenger and long non-coding RNA.

A key lesson from sequencing is that the EV RNA population is far more diverse than microRNA alone. Vesicles carry abundant fragments of transfer RNA and ribosomal RNA, along with Y RNA, piRNA, small nucleolar RNA and other species, and in many preparations microRNAs are a minority of the reads. Some studies have found that ribosomal and transfer RNA fragments are relatively enriched in EVs while microRNAs are comparatively depleted relative to the donor cell, a reminder that the vesicular transcriptome has its own composition rather than mirroring the cytoplasm.

Two practical issues dominate. First, library preparation introduces bias: standard ligation-based protocols are optimised for the end chemistry of microRNAs and under-represent other small RNAs, which is why specialised methods exist to broaden coverage. Second, and more serious for biomarker work, much of the microRNA in blood is not inside vesicles at all; it travels bound to Argonaute proteins or associated with lipoproteins such as HDL. If those non-vesicular carriers co-purify with EVs, a transcriptomic signal attributed to vesicles may actually originate outside them. As with proteomics, the credibility of the result depends on how cleanly the vesicles were separated from the surrounding milieu.

Lipidomics: The Membrane and Its Messengers

Lipids are sometimes overlooked, yet they define the EV membrane and contribute directly to vesicle biogenesis, stability, targeting and uptake. EV lipidomics uses mass spectrometry, either shotgun (direct infusion) or coupled to liquid chromatography, to identify and quantify lipid species across the major classes. The result is a quantitative membrane profile that can distinguish vesicle types, report on the parent cell and, in some diseases, shift in informative ways.

Compared with their parent cells, EV membranes are typically enriched in cholesterol, sphingomyelin, glycosphingolipids and phosphatidylserine, giving them a composition reminiscent of lipid rafts. The externalisation of phosphatidylserine on the vesicle surface is a recurring feature with functional consequences for recognition and uptake, and detailed studies, such as the molecular lipidomics of exosomes from prostate cancer cells, have shown how specific lipid classes are concentrated relative to the originating cell. Beyond their structural and signalling roles, lipids serve a useful analytical purpose: because they are chemically distinct from proteins and nucleic acids, the lipid profile can help confirm vesicle identity and estimate purity.

Lipidomics carries its own caveats. Robust quantification depends on appropriate internal standards and on the conventions of the lipidomics community, and the work is specialised enough that non-experts are advised to collaborate with a dedicated lipidomics laboratory. The recurring contamination problem reappears in lipid form: lipoproteins in plasma overlap with EVs in both size and density and are extremely lipid-rich, so an incompletely purified preparation can yield a lipid profile that reflects co-isolated lipoproteins as much as the vesicles themselves.

Integrating the Layers: Multi-Omics and Databases

No single layer tells the whole story. A protein marker gains meaning when read alongside the RNA and lipid context of the same vesicle population, and integrated multi-omics studies, profiling proteins, RNA and lipids (and sometimes metabolites) from matched samples, are becoming a standard way to characterise EVs in disease. The pay-off is a more complete picture of vesicle identity and function than any one technique provides, and a better chance of distinguishing genuine vesicular signal from contaminant artefact when several independent measurements agree.

Community resources help place new data in context. Curated databases such as Vesiclepedia, a continuously annotated compendium of EV proteins, RNA, lipids and metabolites, and ExoCarta, focused on exosomal cargo, let researchers compare their findings against the accumulated literature and identify which molecules are commonly reported versus genuinely novel. Used carefully, these databases are a sanity check as much as a discovery tool, flagging when a supposed EV marker is in fact a frequent contaminant.

Why Isolation and Purity Determine Cargo Data

A theme runs through all three layers: the analytical platform is rarely the limiting factor, the EV preparation is. Mass spectrometers and sequencers will faithfully report whatever molecules are present, including those that came from co-isolated lipoproteins, free protein or extravesicular RNA. The method used to separate vesicles from that background therefore shapes every downstream conclusion, which is why the field places such emphasis on standardised isolation, purity assessment and transparent reporting.

Tools for EV Isolation and Cargo Analysis

Because cargo data are only as good as the vesicle preparation behind them, the practical foundation of proteomics, transcriptomics and lipidomics is clean, well-characterised isolation. Cell Guidance Systems offers a complementary set of tools spanning that foundation. Exo-spin size-exclusion chromatography columns separate intact EVs from soluble protein and much of the co-isolating lipoprotein and free-RNA background, preserving vesicle integrity for downstream analysis, while EVlution TFF tangential flow filtration supports larger or more concentrated preparations. For quality control, the NTA size profiling service measures particle size distribution and concentration by nanoparticle tracking analysis, providing the characterisation data that rigorous EV reporting requires before any proteomic, transcriptomic or lipidomic claim is made.

Toward Reproducible EV Cargo Analysis

Proteomics, transcriptomics and lipidomics each open a different window onto the molecular cargo of extracellular vesicles, and together they turn a population of nanoparticles into a rich, multi-dimensional readout of cellular state. The evidence that EVs carry selectively packaged proteins, RNA and lipids gives each layer real biological meaning, and the growth of multi-omics and curated databases is steadily improving how that meaning is interpreted. The field's main vulnerability is shared across all three layers and is methodological: results are only as trustworthy as the isolation and characterisation steps that define the vesicles being analysed. Reproducible EV cargo analysis therefore rests on gentle, well-characterised EV preparation and transparent reporting, the practical foundations on which the molecular biology depends.

Cell Guidance Systems Products and Services for EV Cargo Analysis

EV Isolation. Exo-spin size-exclusion columns and EVlution TFF tangential flow filtration provide gentle, scalable EV purification that separates vesicles from the soluble protein, lipoprotein and non-vesicular RNA that otherwise confound cargo analysis.

EV Characterisation. The NTA size profiling service delivers particle size and concentration data by nanoparticle tracking analysis, the characterisation baseline that proteomic, transcriptomic and lipidomic studies should establish before profiling cargo.

Protein Cargo Tools. For protein-level work, ExoLISA assays provide sensitive quantification of EV-associated proteins, and our exosome antibodies support marker detection, western blotting and immunocapture of defined vesicle populations. Purified exosomes are available as reference material for assay development and method validation.

Full EV Services. Our complete EV and exosome services support projects from isolation through characterisation and analysis, helping ensure that downstream omics data rest on a reproducible vesicle preparation.

References

[1] Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.

[2] Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654-659.

[3] Pocsfalvi G, Stanly C, Vilasi A, et al. Mass spectrometry of extracellular vesicles. Mass Spectrom Rev. 2016;35(1):3-21.

[4] Bandu R, Oh JW, Kim KP. Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology. Exp Mol Med. 2019;51(3):1-10.

[5] Jalaludin I, Lubman DM, Kim J. A guide to mass spectrometric analysis of extracellular vesicle proteins for biomarker discovery. Mass Spectrom Rev. 2023;42(2):844-872.

[6] O'Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21(10):585-606.

[7] Skotland T, Sandvig K, Llorente A. Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res. 2017;66:30-41.

[8] Record M, Carayon K, Poirot M, Silvente-Poirot S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014;1841(1):108-120.

[9] Llorente A, Skotland T, Sylvanne T, et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta. 2013;1831(7):1302-1309.

[10] Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10(12):e1001450.

[11] Keerthikumar S, Chisanga D, Ariyaratne D, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016;428(4):688-692.

[12] EV-TRACK Consortium, Van Deun J, Mestdagh P, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14(3):228-232.

[13] Welsh JA, Goberdhan DCI, O'Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023). J Extracell Vesicles. 2024;13(2):e12404.